Mednet Logo
HomePrimary Care
Primary Care

Primary Care

Physician perspectives on preventive care, chronic disease management, and evidence-based primary care practice.

Recent Discussions

In what cases do you use baclofen for alcohol use disorder?

7
3 Answers

Mednet Member
Mednet Member
Psychiatry · Massachusetts General Hospital

As Dr. @Dr. First Last mentioned, it's generally not a first-line choice (at least in the US). It is much more popular in Europe, but efficacy usually comes at notably higher doses. In one case series from 144 patients treated with baclofen in a French clinic, the mean maximum dose was 211 mg daily ...

What is your preferred first line management of alcohol use disorder with concomitant depression?

2 Answers

Mednet Member
Mednet Member
Primary Care · Yale

The presence of comorbid depression doesn't significantly change the way I think about pharmacotherapy for AUD. I would still consider disulfiram, naltrexone (PO and IM), and acamprosate as equivalent first-line agents. It's worth noting that distinguishing between major depressive disorder and subs...

What is your preferred first line management of alcohol use disorder with concomitant depression?

2 Answers

Mednet Member
Mednet Member
Primary Care · Yale

The presence of comorbid depression doesn't significantly change the way I think about pharmacotherapy for AUD. I would still consider disulfiram, naltrexone (PO and IM), and acamprosate as equivalent first-line agents. It's worth noting that distinguishing between major depressive disorder and subs...

How do you approach screening for occult cardiac or tracheal involvement in a patient with relapsing polychondritis?

3
1 Answers

Mednet Member
Mednet Member
Rheumatology · University of Maryland School of Medicine

Hello! Dynamic CT and echo, if you have suspicion of vasculitis (physical exam, sx), a CTA can help. Happy to discuss your case.

When would you consider long-term cardiac monitoring to look for atrial fibrillation in patients with mitral stenosis given their baseline elevated risk for atrial fibrillation and thrombosis?

3
2 Answers

Mednet Member
Mednet Member
Cardiology · Ucla Health Santa Monica Cardiology

This is a thought-provoking question. Not only is Afib a risk factor for strokes but these strokes can be particularly devastating. While screening for subclinical Afib in large populations is described, there is little data to show that this leads to clinical benefits (1, 2). The benefit of detecti...

Is asymptomatic long QT syndrome a contraindication for starting AIT?

1
1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · Family Allergy And Asthma

No.

What is the rationale/evidence to support doing 4 puffs of albuterol vs. 2 puffs for a reversibility study?

1
3 Answers

Mednet Member
Mednet Member
Allergy & Immunology · University of Washington School of Medicine

The rationale per ATS in 2005 is that 4 puffs of albuterol is higher on the dose-response curve and thus would potentially avoid getting a suboptimal (< 12%, < 200 mL) response from 2 puffs. Having said that, there was a study of this issue in 240 pediatric patients showing non-inferiority of 2 puff...

What is your approach to counseling severely frail older adults regarding their planning for invasive life-sustaining therapy?

2 Answers

Mednet Member
Mednet Member
Geriatric Medicine · Beth Israel Deaconess Medical Center

My approach is pragmatic, evidence-based, and bi-directional. Patients/family make the decision, but I ensure they are fully informed about the pros and cons and provide them time to think through.

Would you initiate anti-arrhythmic drug therapy in patients who are asymptomatic and have normal LV function but with a PVC burden > 20 percent?

4
3 Answers

Mednet Member
Mednet Member
Cardiology · The Cleveland Clinic Foundation

I overall agree with Dr. @Dr. First Last's approach. There are important considerations with high-burden PVCs beyond LVEF. The morphology can be helpful with regard is this consistent or atypical appearance of idiopathic PVCs. I will typically do an assessment for underlying structural heart disease...

With the growth of non-alcoholic beverages (e.g., NA beer, liquor, etc), how do you approach a patient's consumption of these products in the setting of alcohol related liver disease?

2
2 Answers

Mednet Member
Mednet Member
Hepatology · UC San Diego Health

This is definitely a challenging conundrum to deal with. Historically, even the NA beverages would have 0.5% alcohol, so they weren't truly NA. With time, that has seemingly changed. Regardless, my approach is the same. I strongly advise against the idea that NA beverages are allowed. Mostly because...